New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
December 11, 2012
09:14 EDTMWIV, IDXX, WOOF, HSKA, PDCO, ABAXBofA/Merrill to host a summit
Animal Health Summit is being held in Boston on December 11.
News For IDXX;ABAX;HSKA;MWIV;PDCO;WOOF From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
July 29, 2015
09:04 EDTHSKAHeska reports Q2 EPS 17c, consensus 10c
Reports Q2 revenue $23.91M, consensus $24.11M. Reports Q2 Core Companion Animal Health revenue up 19% to $20.8M. Reports Q2 Blood Analyzer and Consumables revenue up 29% to $10.1M.
08:08 EDTWOOFVCA Inc. raises FY15 EPS view to $2.25-$2.35 from $2.17-$2.27
Subscribe for More Information
08:07 EDTWOOFVCA Inc. reports Q2 EPS 70c, consensus 65c
Subscribe for More Information
July 24, 2015
10:00 EDTABAXOn The Fly: Analyst Downgrade Summary
Today's noteworthy downgrades include: Abaxis (ABAX) downgraded to Hold from Buy at Canaccord... Buffalo Wild Wings (BWLD) downgraded to Neutral from Buy at Dougherty... CF Industries (CF) downgraded on nitrogen outlook at RBC Capital... Capital One (COF) downgraded to Neutral from Overweight at JPMorgan... Cepheid (CPHD) downgraded to Sell from Hold at Evercore ISI... Constant Contact (CTCT) downgraded to Neutral from Outperform at Baird... Equifax (EFX) downgraded to Neutral from Outperform at Baird... Hannover Re (HVRRY) downgraded to Underweight from Neutral at JPMorgan... IAMGOLD (IAG) downgraded to Underperform from Market Perform at Raymond James... MSA Safety (MSA) downgraded to Neutral from Accumulate at Global Hunter... MTU Aero (MTUAY) downgraded to Underperform from Buy at BofA/Merrill... Macy's (M) downgraded to Underweight from Neutral at Atlantic Equities... Sunesis (SNSS) downgraded to Hold from Buy at Cantor... Superior Drilling (SDPI) downgraded to Hold from Buy at Wunderlich... TrueCar (TRUE) downgraded to Equal Weight from Overweight at Stephens... United Rentals (URI) downgraded to Outperform from Top Pick at RBC Capital... WESCO (WCC) downgraded to Equal Weight from Overweight at Stephens.
06:17 EDTABAXAbaxis downgraded to Hold from Buy at Canaccord
Subscribe for More Information
July 23, 2015
16:03 EDTABAXAbaxis reports Q1 EPS 31c, consensus 28c
Reports Q1 revenue $53.1M, consensus $53.82M.
10:00 EDTIDXXOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
08:34 EDTIDXXIDEXX upgraded to Hold from Sell at Feltl
Feltl upgraded IDEXX to Hold and increased its price target to $69.50 from $61.50 based on an improved growth outlook and valuation.
07:28 EDTABAXAbaxis well positioned despite increased competition, says Canaccord
Subscribe for More Information
July 20, 2015
08:38 EDTIDXXAnalyst predicts Zoetis merges with Bayer unit, not Valeant
Zoetis (ZTS) in recent months has been the subject of takeover speculation, possibly for Valeant (VRX), but a Jefferies analyst told investors today in a research note that he views a deal with a unit of healthcare giant Bayer (BAYRY) as "highly likely" for the animal medicine company. BACKGROUND: Bill Ackman of Pershing Square, who owns stakes in both Zoetis and Valeant, said in early May while speaking on CNBC that Zoetis is a "great” business on a standalone basis, but he also spoke of the company's strategic value. Ackman added, however, that he was "not sure" that Valeant was the best acquirer of Zoetis. Subsequently, in late June, The Wall Street Journal reported that Valeant made a preliminary approach regarding a potential deal to buy Zoetis. CNBC's David Faber said the next day, citing his own sources, that Valeant reached out to Zoetis as a courtesy to common shareholder Ackman and was unlikely to pursue an acquisition of the company, though he cautioned then Valeant could change its approach and pursue a deal. BAYER: Jefferies analyst Jeffrey Holford said in a note today that he views a tie-up between Zoetis and Bayer's Animal Health business in 2016 as "highly likely." He sees Mylan's (MYL) acquisition of Abbott's (ABT) non‑U.S. developed markets specialty and branded generics business as a potential proxy for how a transaction could be structured, adding that such a "spinversion" could achieve up to 36% long-term earnings accretion for Zoetis. Holford reiterated a Buy rating on Zoetis with a $60 price target, while downgrading Bayer to Hold, citing valuation following the recent outperformance of its shares. IDEXX: While being discussed as a target, some analysts have also opined on companies that Zoetis could pursue as a buyer. On June 29, Canaccord said that in investor meetings with IDEXX (IDXX) executives declined to comment on Zoetis' potential interest in scaling up its animal health diagnostics business. Canaccord added that it thought Zoetis could make a bid for IDEXX. The firm reiterated its Buy rating and $80 price target on IDEXX shares at that time. PRICE ACTION: Since June 25, the day the Journal first reported on Valeant's preliminary takeover approach to Zoetis, the animal health company's shares have dropped nearly 4%. Zoetis closed down 20c to $47.80 on Friday.
July 15, 2015
10:20 EDTWOOFVCA Inc. initiated with a Buy at Cleveland Research (pre-open)
Subscribe for More Information
09:41 EDTIDXXIDEXX should be watched after 'curious' board change, dealReporter says
IDEXX Laboratories (IDXX), which analysts have previously speculated could be a takeover target for Zoetis (ZTS), should be watched for any possible M&A hints after the "curious addition" of Advanced Micro Devices (AMD) Chairman Bruce Claflin to its board yesterday, said dealReporter, according to contacts.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use